Showing results (11-20 of 97) with videos related to
Sort By:
Pageof 10
Clinics in Liver Disease|November 5, 2003
Genetic factors in the pathogenesis of primary biliary cirrhosisDavid E J Jones, Peter T DonaldsonLiver International : Official Journal of the International Association for the Study of the Liver|June 24, 2018
Fatigue in chronic liver disease: New insights and therapeutic approachesMark G Swain, David E J JonesJournal of Hepatology|February 4, 2012
Managing systemic symptoms in chronic liver diseaseJulia L Newton, David E J JonesImmunology|October 13, 2006
Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta productionAndrea Broad, John A Kirby, David E J Jones, et al.Current Medicinal Chemistry|October 5, 2006
Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapyAndrea Broad, David E J Jones, John A KirbySeminars in Liver Disease|July 25, 2014
The new epidemiology of primary biliary cirrhosisLaura Griffiths, Jessica K Dyson, David E J JonesJournal of Hepatology|November 9, 2017
Access to care in rare liver diseases: New challenges and new opportunitiesDavid E J Jones, Ekkehard Sturm, Ansgar W LohseClinics in Liver Disease|November 24, 2015
Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisLaura Jopson, Jessica K Dyson, David E J JonesDigestive Diseases (Basel, Switzerland)|March 2, 2017
Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing CholangitisVinod S Hegade, David E J Jones, Gideon M HirschfieldDigestive Diseases (Basel, Switzerland)|May 4, 2017
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?Lin Lee Wong, Vinod S Hegade, David E J JonesPageof 10